Microbial Metabolites Control the Thymic Development of Mucosal-Associated Invariant T Cells

Francois Legoux,Deborah Bellet,Celine Daviaud,Yara El Morr,Aurelie Darbois,Kristina Niort,Emanuele Procopio,Marion Salou,Jules Gilet,Bernhard Ryffel,Aurelie Balvay,Anne Foussier,Manal Sarkis,Ahmed El Marjou,Frederic Schmidt,Sylvie Rabot,Olivier Lantz
DOI: https://doi.org/10.1126/science.aaw2719
IF: 56.9
2019-01-01
Science
Abstract:How the microbiota modulate immune functions remains poorly understood. Mucosal-associated invariant T (MAIT) cells are implicated in mucosal homeostasis and absent in germ-free mice. Here, we show that commensal bacteria govern murine MAIT intrathymic development, as MAIT cells did not recirculate to the thymus. MAIT development required RibD expression in bacteria, indicating that production of the MAIT antigen 5-(2-oxopropylideneamino)-6-d-ribitylaminouracil (5-OP-RU) was necessary. 5-OP-RU rapidly traveled from mucosal surfaces to the thymus, where it was captured by the major histocompatibility complex class Ib molecule MR1. This led to increased numbers of the earliest MAIT precursors and the expansion of more mature receptor-related, orphan receptor γt-positive MAIT cells. Thus, a microbiota-derived metabolite controls the development of mucosally targeted T cells in a process blurring the distinction between exogenous antigens and self-antigens.
What problem does this paper attempt to address?